GLYCARDIAL DIAGNOSTICS
GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event.
GLYCARDIAL DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics Life Science Medical Device Pharmaceutical
Founded:
2017-09-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.glycardial.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.37 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Investors List
Horizon 2020
Horizon 2020 investment in Grant - GlyCardial Diagnostics
EIT Health
EIT Health investment in Grant - GlyCardial Diagnostics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - GlyCardial Diagnostics
Official Site Inspections
http://www.glycardial.com
- Host name: 104.21.64.1
- IP address: 104.21.64.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GlyCardial Diagnostics"
GlyCardial Diagnostics - Crunchbase Company Profile & Funding
GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a …See details»
GlyCardial Diagnostics - LinkedIn
GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a …See details»
GlyCardial Diagnostics Company Profile 2024: Valuation, Funding ...
GlyCardial Diagnostics was founded in 2017. Where is GlyCardial Diagnostics headquartered? GlyCardial Diagnostics is headquartered in Barcelona, Spain. What is the size of GlyCardial …See details»
GlyCardial Diagnostics - VentureRadar
GlyCardial Diagnostics is a spin-off company of the IR-Hospital de la Santa Creu i Sant Pau and the Spanish National Research Council (CSIC) incorporated in 2017, focused on the …See details»
The First In Vitro Diagnostic Device for the Early Detection
Aug 10, 2022 GlyCardial Diagnostics, S.L. is a small company of 4 (3 women, 1 man) but with the successful completion of the SMEI Phase 1 and 2 we estimate an EBITDA of around …See details»
GlyCardial Diagnostics - Funding, Financials, Valuation & Investors
GlyCardial Diagnostics is a spin-off company of the IR-Hospital de la Santa Creu i Sant Pau and the Spanish National Research Council. Search Crunchbase. ... How much funding has this …See details»
GlyCardial Diagnostics - Contacts, Employees, Board Members, …
Organization. GlyCardial Diagnostics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of …See details»
GlyCardial Diagnostics moves its headquarters to …
GlyCardial Diagnostics, founded in 2017, is a spinoff of the Research Institute of the Hospital de la Santa Creu i Sant Pau and the Spanish National Research Council , promoted by Judit Cubedo, Doctor in Biology, as a result of a …See details»
GlyCardial Diagnostics - Craft
GlyCardial Diagnostics is a company focused on the development of Apo J-Glyc, a biomarker for the diagnosis and prognosis of myocardial ischemia. Its technology is based on the …See details»
Sant Pau - Institut de Recerca
Our spin-off company GlyCardial Diagnostics has received the SME instrument phase II funding of the H2020 programme We are proud to anounce that our spin-off company GlyCardial …See details»
Board Director at GlyCardial Diagnostics - The Org
Board Director at GlyCardial Diagnostics. Join to edit. About. Sebastián Chiavenna has over 18 years of professional experience in the fields of biotechnology, marketing, and project …See details»
GlyCardial Gets €2.4M to Spot Myocardial Infarction Before it's …
Nov 13, 2017 GlyCardial Diagnostics believes it has the technology to prevent premature myocardial infarctions, 80% of which are preventable. Barcelona-based GlyCardial …See details»
A novel biomarker fills the gap in diagnosis of myocardial
Nov 21, 2022 Early diagnosis of ischaemia is essential to prevent progression of heart damage and tissue necrosis. The EU-funded AGLYC project has made an important contribution in this …See details»
GlyCardial begins the clinical trial of its novel diagnostic device for ...
GlyCardial Diagnostics, located at the Barcelona Science Park, has announced the enrolment of the first two patients in the EDICA trial: a multicenter international clinical study for the early …See details»
Gemma Vilahur - Co-founder @ GlyCardial Diagnostics - Crunchbase
Primary Organization . GlyCardial Diagnostics . Location Barcelona, Catalonia, Spain; Regions European Union (EU), Europe, Middle East, and Africa (EMEA) ... GlyCardial Diagnostics …See details»
PCSK9 in Myocardial Infarction and Cardioprotection: Importance …
Nov 12, 2020 GV has a Research Grant of AstraZeneca and is founder of the Spin-off Glycardial Diagnostics SL. IA, II, and MT declare that they have not a potential conflict of interest. The …See details»
Judit Cubedo, CEO of GlyCardial, finalist for the EU Prize for …
Judit Cubedo, co-founder and CEO of GlyCardial Diagnostics, is one of the twenty-one women selected as finalists for the EU Prize for Women Innovators 2020, an award given annually to …See details»
Co-Founder and CSO @ GlyCardial Diagnostics - Crunchbase
Primary Organization . GlyCardial Diagnostics . Location Barcelona, Catalonia, Spain; Regions European Union (EU), Europe, Middle East, and Africa (EMEA) ... GlyCardial Diagnostics Co …See details»
Antithrombotic therapy for patients with chronic coronary …
### Learning objectives Globally, much morbidity and premature mortality arises from coronary artery disease (CAD). Coronary artery atherothrombosis is the dominant cause of acute …See details»
GlyCardial completes patient enrolment in the EDICA trial to …
GlyCardial Diagnostics, based in the Barcelona Science Park, announces the completion of the recruitment in the EDICA trial, a multicenter international in vitro study –which will involve ten …See details»